Cabaletta Bio (CABA) Exchange Rate Effect (2024 - 2025)
Cabaletta Bio (CABA) posted quarterly Exchange Rate Effect of -$8000.0 for Q4 2025, up 60.0% year-over-year from -$5000.0 in Q4 2024, and up 27.27% quarter-over-quarter from -$11000.0 in Q3 2025.
Cabaletta Bio (CABA) Exchange Rate Effect (2024 - 2025) Analysis & Trends
Cabaletta Bio's Exchange Rate Effect history runs 2 years deep, the most recent figure standing at -$8000.0 for Q4 2025.
- In Q4 2025, Exchange Rate Effect rose 60.0% year-over-year to -$8000.0; the TTM figure through Dec 2025 stood at $19000.0 (up 195.0% YoY), while the FY2025 annual figure was $19000.0, up 195.0% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at -$8000.0, up from -$11000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $31000.0 in Q2 2025, with the low at -$20000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | -20,000.00 |
| Dec 31, 2024 | -20,000.00 |